Poxel

    OverviewSuggest Edit

    Poxel, a research integrated pharmaceutical company, engages in developing products for metabolic diseases with a focus on Type 2 diabetes. It offers Imeglimin, an orally active adjunct for diet and exercises to improve glycemic control in patients with type 2 diabetes; Glucagon-like peptide-1 receptor agonist, an incretin hormone displaying glucose-dependent stimulation of insulin secretion and restoring the normal profile of insulin release in response to glucose; and AMP-activated protein kinase activator, an enzyme that controls whole-body energy metabolism by regulating glucose and fatty acid homeostasis in various peripheral tissues, such as skeletal muscle and liver. 
    TypePublic
    Founded2009
    HQLyon, FR
    Websitepoxelpharma.com
    Employee Ratings0

    Latest Updates

    Employees (est.) (Feb 2019)34(+36%)

    Key People/Management at Poxel

    Thomas Kuhn

    Thomas Kuhn

    CEO, Co-Founder

    Poxel Office Locations

    Poxel has an office in Lyon
    Lyon, FR (HQ)
    200 Avenue Jean Jaures
    Show all (1)

    Poxel News and Updates

    Poxel Frequently Asked Questions

    • When was Poxel founded?

      Poxel was founded in 2009.

    • Who are Poxel key executives?

      Poxel's key executives are Thomas Kuhn.

    • How many employees does Poxel have?

      Poxel has 34 employees.

    • Who are Poxel competitors?

      Competitors of Poxel include Promethera Biosciences, RaySearch Laboratories and GNS Healthcare.

    • Where is Poxel headquarters?

      Poxel headquarters is located at 200 Avenue Jean Jaures, Lyon.

    • Where are Poxel offices?

      Poxel has an office in Lyon.

    • How many offices does Poxel have?

      Poxel has 1 office.